Glenn F. Pierce
Director/Board Member at VOYAGER THERAPEUTICS, INC.
Net worth: 202 846 $ as of 2024-03-30
Profile
Glenn F.
Pierce's current job(s) include being the Director at the World Federation of Hemophilia since 2015, an Independent Director at Voyager Therapeutics, Inc. since 2017, and the Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc. since 2009.
He is also a Member of the American Society of Hematology, The International Society On Thrombosis & Haemostasis, and the Hemostasis & Thrombosis Research Society.
Dr. Pierce's former job(s) include being an Independent Director at Global Blood Therapeutics, Inc. from 2016 to 2022.
He was also a Principal at Amgen, Inc., Vice President-Research & Clinical Development at Avigen, Inc., Chief Medical Officer & SVP-Global Medical Affairs at Biogen, Inc. from 2009 to 2014, Vice President-Applied Research Hematology at Bayer Healthcare LLC, Vice President-PreClinical Development at Prizm Pharmaceuticals, Inc. from 1994 to 1998, and Vice President-Therapeutic Product Development at Selective Genetics, Inc. from 1998 to 2002.
He also served as the President of the National Hemophilia Foundation and was the Chief Medical Officer at Ambys Medicines, Inc. from 2018 to 2020.
Dr. Pierce's education includes a graduate degree from Washington University in St. Louis and undergraduate and doctorate degrees from Case Western Reserve University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-05 | 21,788 ( 0.04% ) | 202 846 $ | 2024-03-30 |
Glenn F. Pierce active positions
Companies | Position | Start |
---|---|---|
VOYAGER THERAPEUTICS, INC. | Director/Board Member | 2017-01-04 |
Hemostasis & Thrombosis Research Society | Corporate Officer/Principal | - |
World Federation of Hemophilia | Director/Board Member | 2014-12-31 |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The International Society On Thrombosis & Haemostasis | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2011-01-24 |
Former positions of Glenn F. Pierce
Companies | Position | End |
---|---|---|
GLOBAL BLOOD THERAPEUTICS, INC. | Director/Board Member | 2022-10-04 |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
BIOGEN INC. | Chief Tech/Sci/R&D Officer | 2014-04-30 |
░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Glenn F. Pierce
Washington University in St. Louis | Graduate Degree |
Case Western Reserve University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
AMGEN INC. | Health Technology |
BIOGEN INC. | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
Private companies | 12 |
---|---|
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
World Federation of Hemophilia | |
Prizm Pharmaceuticals, Inc. | Health Technology |
Selective Genetics, Inc.
Selective Genetics, Inc. Medical SpecialtiesHealth Technology Selective Genetics, Inc. developed gene therapeutics and DNA devices for tissue repair and regeneration. The company was founded by Thomas S. Porter in 1998 and was headquartered Encinitas, CA. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
National Hemophilia Foundation | |
The International Society On Thrombosis & Haemostasis | |
Hemostasis & Thrombosis Research Society | |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Glenn F. Pierce